Objective: The study was performed to determine the attitude of cancer patients with symptoms of nausea and vomiting towards complementary and holistic treatment. Material and Methods: The study sample included the 138 cancer patients with 3 or more nausea and vomiting according to Visual Anolog Scale were included in the study. Information Form, Attitudes towards Holistic Complementary and Alternative Medicine Scale, The Rhodes Index of Nausea, Vomiting, and Retching were used as data collection of this study. Results: Cancer patients were found to have a positive attitude towards complementary and holistic therapy. Although cancer patients participating in the study often experienced nausea and vomiting, symptom distress was also low. There was a positive correlation between symptom frequency and the symptom occurrence and holistic health dimensions (p˂0.05). Moreover, a positive correlation was found between the symptom occurrence of the patients and their attitudes towards alternative medicine (p˂0.05). Conclusion: Cancer patients have a positive attitude towards complementary and holistic therapy in relieving the symptoms of nausea and vomiting. It is recommended to create guidelines for determining effective strategies and using them properly in mixed therapies.
Keywords: Cancer patients; nausea and vomiting; complementary and holistic treatment; attitude evaluation
Amaç: Bu araştırma, bulantı ve kusma semptomu olan kanser hastalarının, tamamlayıcı ve bütüncül tedaviye karşı tutumlarını belirlemek amacıyla yapıldı. Gereç ve Yöntemler: Çalışma, Vizüel Analog Skalaya göre 3 ve üzerinde bulantı kusması olan ve kanser tanısı alan 138 hastanın katılımı ile gerçekleştirildi. Verilerin toplanmasında Sosyodemografik Bilgi Formu, Bütüncül Tamamlayıcı ve Alternatif Tıbba Karşı Tutum Ölçeği ve Rhodes Bulantı, Kusma ve Öğürme İndeksi kullanıldı. Bulgular: Kanser hastalarının tamamlayıcı ve alternatif tıbba karşı tutumlarının pozitif olduğu belirlendi. Çalışmaya katılan kanser hastalarında bulantı ve kusma görülme sıklığı yüksek olsa da semptom sıkıntısı düşüktü. Semptom deneyimleri ve semptom oluşumlarıyla bütüncül sağlık boyutu arasında pozitif korelasyon belirlendi (p˂0,05). Ayrıca hastaların semptom oluşumlarıyla tamamlayıcı ve alternatif tıbba karşı tutumları arasında pozitif korelasyon saptandı (p˂0,05). Sonuç: Bu araştırmada, bulantı ve kusma semptomu olan kanser hastalarının, tamamlayıcı ve bütüncül tedaviye karşı tutumlarının olumlu olduğu belirlendi. Tamamlayıcı ve bütüncül tedaviye yönelik etkili stratejiler belirlemek ve bunları farmakolojik tedavilerle birlikte doğru kullanmak için kılavuzlar oluşturulması önerilir.
Anahtar Kelimeler: Kanser hastaları; bulantı ve kusma; tamamlayıcı ve bütünleyici tedaviler; tutum değerlendirmesi
- Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pi-eros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941-53. [PubMed]
- Mayor S. Side-effects of cancer drugs are under-reported in trials. Lancet Oncol. 2015;16(3):e107. [PubMed]
- Beaver CC, Magnan MA. Managing chemotherapy side effects: achieving reliable and equitable outcomes. Clin J Oncol Nurs. 2016;20(6):589-91. [PubMed]
- Navari RM. managing nausea and vomiting in patients with cancer: what works. oncology (Williston Park). 2018;32(3):121-5, 131, 136. [PubMed]
- Razvi Y, Chan S, McFarlane T, McKenzie E, Zaki P, DeAngelis C, et al. ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients. Support Care Cancer. 2019;27(1):87-95. [PubMed]
- Saneei Totmaj A, Emamat H, Jarrahi F, Zarrati M. The effect of ginger (Zingiber officinale) on chemotherapy-induced nausea and vomiting in breast cancer patients: A systematic literature review of randomized controlled trials. Phytother Res. 2019;33(8):1957-65. [PubMed]
- Adel N. Overview of chemotherapy-induced nausea and vomiting and evidence-based therapies. Am J Manag Care. 2017;23(14 Suppl):S259-S65. [PubMed]
- Crichton M, Marshall S, Marx W, McCarthy AL, Isenring E. Efficacy of ginger (Zingiber officinale) in ameliorating chemotherapy-induced nausea and vomiting and chemotherapy-related outcomes: a systematic review update and meta-analysis. J Acad Nutr Diet. 2019;119(12):2055-68. [PubMed]
- Mapp CP, Hostetler D, Sable JF, Parker C, Gouge E, Masterson M, et al. Peppermint oil: evaluating efficacy on nausea in patients receiving chemotherapy in the ambulatory setting. Clin J Oncol Nurs. 2020;24(2):160-4. [PubMed]
- Lv C, Shi C, Li L, Wen X, Xian CJ. Chinese herbal medicines in the prevention and treatment of chemotherapy-induced nausea and vomiting. Curr Opin Support Palliat Care. 2018;12(2):174-80. [PubMed]
- Abuelgasim KA, Alsharhan Y, Alenzi T, Alhazzani A, Ali YZ, Jazieh AR. The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia. BMC Complement Altern Med. 2018;18(1):88. [PubMed] [PMC]
- Buckner CA, Lafrenie RM, Dénommée JA, Caswell JM, Want DA. Complementary and alternative medicine use in patients before and after a cancer diagnosis. Curr Oncol. 2018;25(4):e275-e81. [PubMed] [PMC]
- Gras M, Vallard A, Brosse C, Beneton A, Sotton S, Guyotat D, et al. Use of complementary and alternative medicines among cancer patients: a single-center study. Oncology. 2019;97(1):18-25. [PubMed]
- Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A. Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther. 2005;4(4):274-86. [PubMed]
- Molassiotis A, Fernández-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16(4):655-63. [PubMed]
- Liew AC, Peh KK, Tan BS, Zhao W, Tangiisuran B. Evaluation of chemotherapy-induced toxicity and health-related quality of life amongst early-stage breast cancer patients receiving Chinese herbal medicine in Malaysia. Support Care Cancer. 2019;27(12):4515-24. [PubMed]
- Ozturk R, Satir DG, Sevil U. Use of complementary and alternative medicine and attitudes in patients with gynecological cancers. European Journal of Therapeutics. 2016 22(3):141-7. DOI: 10.5152/EurJTher. 2016. 006
- Vanaki Z, Matourypour P, Gholami R, Zare Z, Mehrzad V, Dehghan M. Therapeutic touch for nausea in breast cancer patients receiving chemotherapy: Composing a treatment. Complement Ther Clin Pract. 2016;22:64-8. [PubMed]
- Yarney J, Donkor A, Opoku SY, Yarney L, Agyeman-Duah I, Abakah AC, et al. Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross-sectional study. BMC Complement Altern Med. 2013;13:16. [PubMed] [PMC]
- West HJ. Complementary and Alternative Medicine in Cancer Care. JAMA Oncol. 2018;4(1):139. [PubMed]
- Hyland ME, Lewith GT, Westoby C. Developing a measure of attitudes: the holistic complementary and alternative medicine questionnaire. Complement Ther Med. 2003;11(1):33-8. [PubMed]
- Erci B. Attitudes towards holistic complementary and alternative medicine: a sample of healthy people in Turkey. J Clin Nurs. 2007;16(4):761-8. [PubMed]
- Rhodes VA, McDaniel RW. Nausea, vomiting, and retching: complex problems in palliative care. CA Cancer J Clin. 2001;51(4):232-48 quiz 249-52. Erratum in: CA Cancer J Clin 2001;51(5):320. [Crossref] [PubMed]
- Genç F. The effects of acupressure on nausea, vomiting and anxiety associated with chemotherapy in breast cancer patients [Doctoral Thesis]. Erzurum: Atatürk University; 2010. [Link]
- Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer. 2000;8(3):175-9. [PubMed]
- Pang L, de la Cruz M, Wu J, Liu D, Naqvi M, Bruera E. Symptom frequency and change of oldest old cancer patients. Support Care Cancer. 2019;27(11):4165-70. [PubMed]
- Miaskowski C, Cooper BA, Paul SM, Dodd M, Lee K, Aouizerat BE, et al. Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum. 2006;33(5):E79-89. [PubMed]
- Booth CM, Clemons M, Dranitsaris G, Joy A, Young S, Callaghan W, et al. Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study. J Support Oncol. 2007;5(8):374-80. [PubMed]
- Sloan JA, Goldberg RM, Sargent DJ, Vargas-Chanes D, Nair S, Cha SS, et al. Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. J Clin Oncol. 2002;20(6):1491-8. [PubMed]
- Whorton JC. The history of complementary and alternative medicine. In: Cuellar NG, ed. Conversations in Complementary and Alternative Medicine: Insights and Perspectives From Leading Practitioners. 1st ed. Massachusetts, ABD: Jones and Bartlett Publishers, Inc; 2006. p.1-8. [Link]
- Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the use of complementary health approaches among adults: United States, 2002-2012. Natl Health Stat Report. 2015;(79):1-16. [PubMed] [PMC]
- Deng G, Cassileth BR. Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance. CA Cancer J Clin. 2005;55(2):109-16. [PubMed]
- Qureshi M, Zelinski E, Carlson LE. Cancer and complementary therapies: current trends in survivors' ınterest and use. Integr Cancer Ther. 2018;17(3):844-53. [PubMed] [PMC]
- Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer. 1998;83(4):777-82. [PubMed]
- Kav S, Hanoğlu Z, Algıer L. Use of complementary and alternative medicine by cancer patients in Turkey: A literature review. International Journal of Hematology and Oncology 2008;18(1):32-8. [Link]
.: İşlem Listesi